Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,110 GBX | -0.46% | -2.10% | +14.25% |
May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 12,370.00 | 12,370.00 | 12,370.00 |
Spread/Res. | -2.10% | -2.10% | -2.10% |
Spread/Supp. | +5.32% | +9.45% | +10.63% |
Support | 11,498.00 | 11,064.00 | 10,946.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC